表現與耐力組合
一套研究組合，文獻關注研究對象輸出指標、VO2 利用及肌耐力的改善。
What's in the stack
3 precision-matched compounds · 7 vials total for the 10-week cycle.
About the 表現與耐力組合
The Performance & Endurance Stack pairs systemic growth-hormone signalling (HGH) with a mitochondrially-derived metabolic peptide (MOTS-c) and the most-studied GH secretagogue pairing in pre-clinical literature (CJC-1295 + Ipamorelin). The combination is designed for research applications investigating performance, endurance, and recovery-pathway modulation in athletic-research populations.
The 10-week cycle structure reflects the longer adaptation windows that performance and endurance research literature typically uses — shorter windows underestimate the steady-state effects of GH secretagogues, while longer windows risk confounding adaptation effects with the intervention itself.
All compounds are HPLC-verified to ≥99% purity, batch-traceable, and ship from Australian stock. The kit is supplied for laboratory research use only and is not represented for human therapeutic use.
Why these compounds together
Human growth hormone (HGH) provides systemic anabolic, recovery, and metabolic signalling — the foundational hormone whose pulsatile rhythm is the central focus of the broader research literature on GH-axis modulation. The protocol includes HGH as the systemic backbone of the stack.
CJC-1295 + Ipamorelin amplify endogenous GH release through complementary receptor pathways. CJC-1295 (a GHRH analogue) binds the GHRH receptor on pituitary somatotrophs; Ipamorelin (a selective ghrelin-receptor agonist) binds the growth-hormone secretagogue receptor. The two pathways are independent but synergistic — combining them produces a larger pulsatile GH response in research models than either compound alone, while leaving the natural pulsatile rhythm intact.
MOTS-c covers the mitochondrial side of the performance question. Mitochondrial output is the rate-limiting factor for sustained endurance work, and MOTS-c is studied as a putative AMPK pathway activator that supports mitochondrial fatty-acid oxidation and exercise capacity. The pairing of GH-axis signalling with mitochondrial-pathway support is designed to cover both anabolic and oxidative-output sides of the performance research question.
Cycle structure
The 10-week cycle aligns with common adaptation windows in performance and GH-axis research literature. Phase 1 (weeks 1-3) establishes baseline measurements and dose titration; phase 2 (weeks 4-8) covers the peak intervention window; phase 3 (weeks 9-10) covers taper and post-intervention measurement.
Researchers should reference primary literature for protocol-specific dosing — the kit is supplied as research materials, not as a fixed clinical regimen.
Why these compounds together
HGH 提供全身合成代謝與恢復訊號，MOTS-c 支援粒線體輸出，CJC + Ipamorelin 配對驅動內源性 GH 脈衝。研究顯示對輸出與耐力指標具有協同效應。
以大訓練量、高強度進行研究的進階研究者。
Research cycle structure
表現與耐力組合 — frequently asked questions
What peptides are used for muscle growth research?
The most extensively studied compounds in muscle-growth research include human growth hormone (HGH), GHRH analogues (CJC-1295, Tesamorelin), GH secretagogues (Ipamorelin), and IGF-1 family peptides. Pairing of CJC-1295 with Ipamorelin is the most common combination in pre-clinical GH-axis research. The Quantum Labs Performance & Endurance Stack pairs HGH with the CJC + Ipamorelin combination plus MOTS-c for mitochondrial-pathway support.
What is the difference between HGH and GH secretagogues?
HGH provides direct exogenous growth-hormone signalling. GH secretagogues (CJC-1295, Ipamorelin, Tesamorelin) stimulate the pituitary to release endogenous GH in a more naturalistic pulsatile pattern. Research protocols often pair the two — exogenous HGH provides baseline coverage, secretagogues preserve pulsatile rhythm. The Performance Stack uses both.
Is the Performance Stack legal in Australia?
HGH is a prescription-only medicine (S4) in Australia. The Performance Stack is supplied for research and laboratory use only, not for human therapeutic supply. Researchers should ensure their use complies with applicable institutional and regulatory requirements. Quantum Labs supplies this stack for laboratory and pre-clinical research use only. It is not represented for human therapeutic use, and questions about clinical dosing or expected personal outcomes should be directed to a qualified medical practitioner.
What does the Performance & Endurance Stack kit contain?
3× HGH vials, 2× MOTS-c vials, 2× CJC-1295 + Ipamorelin vials — sized for the 10-week research cycle. All compounds lyophilised, sealed, HPLC-verified ≥99% purity, batch-traceable. Ships from Australian stock as a single kit.
Is PCT needed for the Performance Stack?
Post-cycle therapy is generally associated with research protocols that suppress the HPG axis (androgen-receptor agonists, SARMs, AAS). The Performance Stack focuses on the GH-IGF-1 axis rather than the HPG axis, so structured PCT is not part of the protocol design. Researchers should monitor the relevant biomarkers for their specific study question.
How long is a typical performance peptide research cycle?
GH-axis research cycles in published literature commonly run 8-16 weeks, with 10 weeks being a frequent middle ground. Shorter cycles underestimate steady-state effects; longer cycles risk confounding adaptation with the intervention. The Performance & Endurance Stack is sized for the 10-week window.
僅供研究使用。 本化合物嚴格用於體外研究及實驗室用途，不得供人體食用或治療用途。購買即確認您為合格研究者，並同意我們的 完整免責聲明。
Ready to start this protocol?
All 7 vials sized for the 10-week cycle, plus the protocol guide PDF. Shipped worldwide.
Not sure? Take the 60-second quiz